ITK inhibition induced in vitro and in vivo anti-tumor activity through downregulating TCR signaling pathway in malignant T cell lymphoma-Reference-Cited by-同舟云学术

ITK inhibition induced in vitro and in vivo anti-tumor activity through downregulating TCR signaling pathway in malignant T cell lymphoma

Published:2019-02-14 Issue:1 Volume:19 Page:
ISSN:1475-2867
Container-title:Cancer Cell International
language:en
Short-container-title:Cancer Cell Int

Author:

Liu Yalu,Wang Xiaogan,Deng Lijuan,Ping Lingyan,Shi Yunfei,Zheng Wen,Lin Ningjing,Wang Xiaopei,Tu Meifeng,Xie Yan,Liu Weiping,Ying Zhitao,Zhang Chen,Pan Zhengying,Wang Xi,Ding Ning,Song Yuqin,Zhu Jun

Funder

National Natural Science Foundation of China

Natural Science Foundation of Beijing Municipality

Capital Foundation of Medical Development

Beijing Municipal Administration of Hospitals' Ascent Plan

Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support

Beijing Municipal Administration of Hospitals Incubating Program

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12935-019-0754-9.pdf

Reference60 articles.

1. Federico M, Rudiger T, Bellei M, Nathwani BN, Luminari S, Coiffier B, Harris NL, Jaffe ES, Pileri SA, Savage KJ, et al. Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project. J Clin Oncol. 2013;31(2):240–6.

2. Rudiger T, Weisenburger DD, Anderson JR, Armitage JO, Diebold J, MacLennan KA, Nathwani BN, Ullrich F, Muller-Hermelink HK, Non-Hodgkin’s Lymphoma Classification P. Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin’s Lymphoma Classification Project. Ann Oncol. 2002;13(1):140–9.

3. Park S, Ko YH. Peripheral T cell lymphoma in Asia. Int J Hematol. 2014;99(3):227–39.

4. Anderson JR, Armitage JO, Weisenburger DD. Epidemiology of the non-Hodgkin’s lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin’s Lymphoma Classification Project. Ann Oncol. 1998;9(7):717–20.

5. Vose J, Armitage J, Weisenburger D, International TCLP. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol. 2008;26(25):4124–30.

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological profiling of a berbamine derivative for lymphoma treatment;Blood Advances;2024-01-10

2. Pyrazolopyridine-based kinase inhibitors for anti-cancer targeted therapy;RSC Medicinal Chemistry;2024

3. Overcoming immune checkpoint blockade resistance in solid tumors with intermittent ITK inhibition;Scientific Reports;2023-09-21

4. Methylation-related genes involved in renal carcinoma progression;Frontiers in Genetics;2023-08-25

5. SOHO State of the Art Updates and Next Questions | New Pathways and New Targets in PTCL: Staying on Target;Clinical Lymphoma Myeloma and Leukemia;2023-08